Recessive Genetic Deregulation Abrogates c-myc Suppression by Interferon and Is Implicated in Oncogenesis

LITERATURE CITED

• Adams, J. M., A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter, and R. L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (London) 318:533–538.
   PubMed Web of Science ®Google Scholar
• Bentley, D. L., and M. Groudine. 1986. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature (London) 321:702–706.
   PubMed Web of Science ®Google Scholar
• Bishop, J. M. 1985. Viral oncogenes. Cell 42:23–38.
   PubMed Web of Science ®Google Scholar
• Cheley, S., and R. Anderson. 1984. A reproducible microanalytical method for the detection of specific RNA sequences by dot-blot hybridization. Anal. Biochem. 137:15–19.
   PubMedGoogle Scholar
• Dalla-Favera, R., S. Martinotti, R. C. Gallo, J. Erikson, and C. M. Croce. 1983. Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 219:963–967.
   PubMed Web of Science ®Google Scholar
• Dani, C. H., N. Mechti, M. Piechaczyk, B. Lebleu, P. H. Jeenteur, and J. M. Blanchard. 1985. Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc. Natl. Acad. Sci. USA 82:4896–4899.
   PubMed Web of Science ®Google Scholar
• Dony, C., M. Kessel, and P. Gruss. 1985. Post-transcriptionalcontrol of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9. Nature (London) 317:636–639.
   PubMedGoogle Scholar
• Dron, M., N. Modjtahedi, O. Brison, and M. G. Tovey. 1986. Interferon modulation of c-myc expression in cloned Daudi cells: relationship to the phenotype of interferon resistance. Mol. Cell. Biol. 6:1374–1378.
   PubMedGoogle Scholar
• Dyson, P. J., and T. H. Rabitts. 1985. Chromatin structure around the c-myc gene in Burkitt lymphomas with upstream and downstream translocation points. Proc. Natl. Acad. Sci. USA 82:1984–1988.
   PubMed Web of Science ®Google Scholar
• Einat, M., D. Resnitzky, and A. Kimchi. 1985. Close links between reduction of c-myc expression by interferon and G0/G1 arrest. Nature (London) 313:597–600.
   PubMed Web of Science ®Google Scholar
• Einat, M., D. Resnitzky, and A. Kimchi. 1985. Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 82:7608–7612.
   PubMed Web of Science ®Google Scholar
• Ernberg, J., S. Einhorn, H. Strander, and G. Klein. 1981. Proliferation inhibitory effect of human α interferon on primary explants of Burkitt lymphoma: inverse relationship to patient survival. Biomedicine (Paris) 35:190–193.
   PubMedGoogle Scholar
• Friedman-Einat, M., M. Revel, and A. Kimchi. 1982. Initial characterization of a spontaneous interferon secreted during growth and differentiation of Friend erythroleukemia cells. Mol. Cell. Biol. 2:1472–1480.
   PubMed Web of Science ®Google Scholar
• Friend, S. H., R. Bernards, S. Rogelj, R. A. Weinberg, J. M. Rapaport, D. M. Albert, and T. P. Dryja. 1986. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (London) 323:643–646.
   PubMed Web of Science ®Google Scholar
• Gonda, T. J., and D. Metcalf. 1984. Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukemia. Nature (London) 310:249–251.
   PubMed Web of Science ®Google Scholar
• Heldin, C. H., and B. Westermark. 1984. Growth factors: mechanism of action and relation to oncogenes. Cell 37:9–20.
   PubMed Web of Science ®Google Scholar
• Jonak, G. J., and E. Knight, Jr. 1984. Selective reduction of c-myc mRNA in Daudi cells by human β-interferon. Proc. Natl. Acad. Sci. USA 81:1747–1750.
   PubMed Web of Science ®Google Scholar
• Kelly, K., B. H. Cochran, C. D. Stiles, and P. Leder. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610.
   PubMed Web of Science ®Google Scholar
• Kimchi, A., D. Resnitzky, R. Bendori, and M. Einat. 1985. Down regulation of the c-myc and the p53 genes by interferon is tightly associated with IFN mediated G0/G1 arrest. p. 205–212. In H. Kirchner and H. Schellenkens (ed.), The biology of the interferon system. Elsevier Science Publishers B.V., Amsterdam.
   Google Scholar
• Klein, G., and E. Klein. 1985. Evolution of tumours and the impact of molecular oncology. Nature (London) 315:190–195.
   PubMed Web of Science ®Google Scholar
• Klein, G., J. Zeuthen, R. Ber, and I. Ernbserg. 1982. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns. JNCI 68:197–202.
   PubMedGoogle Scholar
• Knight, E., Jr., E. D. Anton, D. Fahey, B. K. Friedland, and G. J. Jonak. 1985. Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. Proc. Natl. Acad. Sci. USA 82:1151–1154.
   PubMed Web of Science ®Google Scholar
• Knudson, A. G., Jr. 1985. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 45:1437–1443.
   PubMed Web of Science ®Google Scholar
• Krishnan, L., and C. Baglioni. 1980. Increased levels of (2′-5′) oligo(A) polymerase activity in human lymphoblastoid cells treated with glucocorticoids. Proc. Natl. Acad. Sci. USA 77:6506–6510.
   PubMed Web of Science ®Google Scholar
• Lachman, H. M., and A. I. Skoultchi. 1984. Expression of c-myc changes during differentiation of mouse erythroleukaemia cells. Nature (London) 310:592–594.
   PubMed Web of Science ®Google Scholar
• Land, H., L. F. Parada, and R. A. Weinberg. 1983. Cellular oncogenes and multistep carcinogenesis. Science 222:771–778.
   PubMed Web of Science ®Google Scholar
• Leder, P., J. Battey, G. Lenoir, C. Modulding, W. Murphy, H. Potter, T. Stewart, and R. Taub. 1983. Translocations among antibody genes in human cancer. Science 222:765–771.
   PubMed Web of Science ®Google Scholar
• Lee, W. H., P. Bookstein, F. Hong, L. J. Young, J. Y. Shew, and E. Y.-H. P. Lee. 1987. Human retinoblastoma susceptibility gene: cloning and sequence. Science 235:1394–1395.
   PubMed Web of Science ®Google Scholar
• Merlin, G., J. Chebath, P. Benech, R. Metz, and M. Revel. 1983. Molecular cloning and sequence of partial cDNA for (2′-5′) oligo(A) synthetase mRNA from human cells. Proc. Natl. Acad. Sci. USA 80:4904–4908.
   PubMed Web of Science ®Google Scholar
• Nicola, N. A., D. Metcalf, M. Matsumoto, and G. R. Johnson. 1983. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells: identification as granulocyte colony stimulating factor. J. Biol. Chem. 258:9017–9023.
   PubMed Web of Science ®Google Scholar
• Novick, D., Z. Eshhar, and M. Rubinstein. 1982. Monoclonal antibodies to human α-interferon and their use for affinity chromatography. J. Immunol. 129:2244–2247.
   PubMedGoogle Scholar
• Rabitts, T. H., A. Forster, P. Hamlyn, and R. Baer. 1984. Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. Nature (London) 309:592–597.
   PubMedGoogle Scholar
• Resnitzky, D., A. Yarden, D. Zipori, and A. Kimchi. 1986. Autocrine β-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell 46:31–40.
   PubMed Web of Science ®Google Scholar
• Rushdi, A., K. Nishikura, J. Erikson, R. Watt, G. Rovera, and C. M. Croce. 1983. Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. Science 222:390–393.
   PubMedGoogle Scholar
• Sager, R. 1986. Genetic suppression of tumor formation: a new frontier in cancer research. Cancer Res. 46:1573–1580.
   PubMed Web of Science ®Google Scholar
• Siebenlist, V., L. Hennighausen, J. Battey, and P. Leder. 1984. Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma. Cell 37:381–391.
   PubMed Web of Science ®Google Scholar
• Stewart, T. A., P. K. Pattengale, and P. Leder. 1984. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38:627–637.
   PubMed Web of Science ®Google Scholar
• Takeda, K., S. Iwamoto, H. Sugimoto, T. Takuma, N. Kawatani, M. Noda, A. Masaki, H. Morise, H. Arimura, and K. Konno. 1986. Identity of differentiation inducing factor and tumour necrosis factor. Nature (London) 323:338–340.
   PubMed Web of Science ®Google Scholar
• Taub, R., C. Moulding, J. Battey, W. Murphy, T. Vasicek, G. M. Lenoir, and P. Leder. 1984. Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells. Cell 36:339–348.
   PubMed Web of Science ®Google Scholar
• Westin, E. H., F. Wong-Staal, E. P. Gelmann, R. Dalla Favera, T. S. Papas, J. A. Lautenberger, A. Eva, E. P. Reddy, S. R. Tronick, S. A. Aaronson, and R. C. Gallo. 1982. Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc. Natl. Acad. Sci. USA 79:2490–2494.
   PubMed Web of Science ®Google Scholar
• Yarden, A., and A. Kimchi. 1986. Tumor necrosis factor reduces c-myc expression and cooperates with interferon-γ in HeLa cells. Science 234:1419–1421.
   PubMed Web of Science ®Google Scholar
• Yarden, A., H. Shure-Gottlieb, J. Chebath, M. Revel, and A. Kimchi. 1984. Autogenous production of interferon-β switches on HLA genes during differentiation of histiocytic lymphoma U937 cells. EMBO J. 3:969–973.
   PubMedGoogle Scholar
• Zeuthen, J., G. Klein, R. Ber, G. Masucci, S. Bisballe, S. Povey, P. Terasaki, and P. Ralph. 1982. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers. JNCI 68:179–195.
   PubMedGoogle Scholar